Despite the increased incidence of endometrial cancer in younger women, there is limited research regarding the safety of local, low-dose vaginal estrogen therapy (ET) for survivors. A new study ...

For more than 20 years, hormone therapy for menopause has carried a warning label from the Food and Drug Administration ...

The warning label placed on all estrogen-based treatments since 2003 was based on an outdated and flawed government-funded study.

Women who use vaginal estrogen to manage early menopause after treatment for endometrial cancer may not have an increased risk for recurrence.

As more women seek hormone replacement therapy, or HRT, the shortage of estrogen patches increases, forcing them to look for ...

For many women in the United States who encounter drenching night sweats, sudden hot flashes, debilitating exhaustion and other menopausal symptoms, small estradiol patches worn on the skin have ...

Perrysburg, Ohio – March 02, 2026 – PRESSADVANTAGE – ...

There are other options for hormone therapy.

However, men with higher PSA levels did show modest improvements in survival, suggesting that hormone therapy might be worthwhile for them. PSA (prostate-specific antigen) is produced by the prostate ...

Increased demand for estrogen patches, particularly twice weekly doses, are in short supply nationally, causing delays for patients in Greater Boston.